Omnes

Omnes Capital S.A.S. is a Paris-based venture capital and private equity firm that focuses on direct investments and fund of funds. It specializes in various investment stages, including seed, startup, and growth capital, primarily targeting small and mid-cap enterprises. The firm actively invests across a diverse range of sectors, such as information technology, life sciences, renewable energy, telecommunications, and agri-food, among others. Omnes Capital manages approximately €3.4 billion in assets and has a notable track record, including over 120 supported companies and 14 IPOs in its 16 years of operation. The firm seeks to take minority stakes in its portfolio companies and prefers a board seat to guide their growth. With a commitment to investing between €1 million and €50 million in companies with enterprise values up to €1 billion, Omnes Capital is recognized for its expertise in financing innovative SMEs, particularly in the technology and healthcare sectors. The firm was previously known as Credit Agricole Private Equity and operates additional offices in Brussels and Zurich.

Benjamin Arm

Managing Director of Buyout and Growth Capital

Marc-Philippe Botte

Partner, Renewable Energy

Xavier Brunaud

Director, Tech

Sébastien Cailliau

Director

Delibes Camille

Partner

Etienne Chemel

Principal

Fabien Collangettes

Director of Investments

Laurent Espic

Partner and Head of Small-Cap Buyout and Growth Capital

Benoît Faguer

Director

Marc Gasser

Associate

Simon Hardi

Director

Frederic Mimoun

Partner & Co-Head of Small Cap

Nicolas Noel

Principal

Vincent Ollivier

Investment Director

Laurent Perret

Principal & Director of investments

Fabien Prévost

CEO

Eric Rey

Managing Partner

Serge Savasta

Managing Director, Infrastructure

Martine Sessin-Caracci

Managing Director, Investor Relations and Communication

Thierry Vallet

Director

Jess Wizman

Principal

Caroline Yametti

Director

256 past transactions

DiogenX

Series A in 2023
DiogenX is a preclinical stage biotech company, specializing in the development of pancreatic beta-cell modulators for the treatment of Type 1 (T1D) and Type 2 Diabetes (T2D). The company, which also has research labs in Nice, France, aims to discover and develop a candidate molecule that regenerates pancreatic insulin-producing cells in patients with diabetes, offering benefits in terms of quality of life and survival. It was discovered in the laboratory of Dr. Patrick Collombat (Inserm, CNRS, Nice University) in France, DiogenX is developing an innovative therapy with the potential to be the first beta-cell regeneration drug for diabetes.

VSORA

Venture Round in 2023
VSORA SAS provides digital signal processing (DSP) intellectual property (IP) for 5G wireless networks. Its products include single-core processor and multi-core processor. The company was founded in 2015 and is based in Velizy-Villacoublay, France.

Qubit Pharmaceuticals

Seed Round in 2022
Qubit Pharmaceuticals, incorporated in 2020 and based in Paris, France, develops innovative technology aimed at enhancing pharmaceutical drug discovery. The company offers a drug discovery simulation platform that reduces the cost and duration of preclinical drug development. Utilizing proprietary force field models and molecular dynamics calculations, Qubit's platform conducts virtual screening and visualization to identify promising drug candidates. This approach leverages quantum physics to support biopharmaceutical companies in accelerating their research and development efforts.

Therapixel

Series B in 2022
Therapixel SA designs and develops medical image analytics software for surgeons. The company's products are based on artificial intelligence. Its products include Radvise, an automatic image reading solution; Fluid, a touchless medical image navigation for surgery; Anywhere, a post-processing workstation; and CD-Feed, a CD imports solution for outpatient imaging exams. Therapixel SA was founded in 2013 and is headquartered in Valbonne, France and has additional locations in Australia, China, Pakistan, Iran, Turkey, Poland, Italy, Spain, France, Mexico, Brazil, Chile, and Peru.

Therapixel

Series B in 2022
Therapixel SA designs and develops medical image analytics software for surgeons. The company's products are based on artificial intelligence. Its products include Radvise, an automatic image reading solution; Fluid, a touchless medical image navigation for surgery; Anywhere, a post-processing workstation; and CD-Feed, a CD imports solution for outpatient imaging exams. Therapixel SA was founded in 2013 and is headquartered in Valbonne, France and has additional locations in Australia, China, Pakistan, Iran, Turkey, Poland, Italy, Spain, France, Mexico, Brazil, Chile, and Peru.

Domain Therapeutics

Series A in 2022
Domain Therapeutics SA is a biopharmaceutical company based in Illkirch-Graffenstaden, France, specializing in the discovery and early development of small molecules targeting G Protein-Coupled Receptors (GPCRs). Founded in 2001, the company focuses on developing therapeutics for Central Nervous System diseases and cancer. It employs innovative technologies, including its proprietary DTect-All platform, which identifies both orthosteric and allosteric ligands, including Silent Allosteric Modulators (SAMs). This platform is particularly adept at addressing challenging GPCRs, such as orphan and peptidic receptors. Additionally, Domain Therapeutics offers BioSens-All, a platform designed to explore the signaling complexity associated with GPCR activation. The company, formerly known as Faust Pharmaceuticals SA, rebranded in December 2008 to reflect its focus on GPCR-targeted therapeutics.

Skillup

Venture Round in 2022
Skillup is an educational training and talent management platform that assists companies in researching, comparing, and booking professional training courses. With a database featuring over 20,000 training options and 50,000 reviews, it serves as a comprehensive resource for HR services seeking suitable training for employees. The platform includes a reservation engine and online publication features, along with software tools that streamline the management of training programs, interviews, and skills assessments. By optimizing these processes, Skillup enables employers and HR managers to focus on strategic talent engagement, growth, and retention.

SeqOne

Series A in 2022
SeqOne S.A.S. is a company based in Montpellier, France, that specializes in developing genomic data analysis software for the healthcare industry. Founded in 2017, SeqOne's platform offers end-to-end management of next-generation sequencing (NGS) and bioinformatics data, providing advanced tools for analyzing complex genomic information. The software is designed to deliver medically actionable results across various areas, including oncology, hematological diseases, rare diseases, genetic screening, and hereditary conditions. By addressing the challenges associated with analyzing rich genomic data, SeqOne aims to enhance the accessibility and effectiveness of genomic medicine, thereby facilitating improved treatment options for patients. The company serves both private and public healthcare sectors, contributing to the ongoing transformation of healthcare through the integration of genomic insights.

Corteria Pharmaceuticals

Seed Round in 2021
Corteria Pharmaceuticals is a biotechnology company dedicated to developing innovative therapies for heart failure subpopulations, particularly those experiencing worsening and acute decompensated heart failure. The company focuses on addressing unmet medical needs in this area and aims to provide effective treatments that enhance understanding of the underlying disease biology. Additionally, Corteria's research extends to related conditions such as sarcopenia and obesity, positioning the company to make a significant impact on the management of these interconnected health issues.

Quandela

Venture Round in 2021
Quandela SAS manufactures photonic cubic and semiconductor chips for quantum computing. Its product E-delight is a solid state source of single and highly indistinguishable photons for quantum applications. Quandela SAS was incorporated in 2017 and is based in Palaiseau, France.

Horama SAS

Series B in 2021
Horama SAS is a biotechnology company based in Paris, France, established in 2014. It specializes in developing gene therapy products aimed at treating rare ophthalmic diseases, particularly targeting inherited retinal dystrophies and retinopathies. By utilizing recombinant adeno-associated viral vectors, Horama's therapies aim to deliver a functional copy of mutated genes to affected retinal cells. This approach seeks to restore normal cell function, prevent further deterioration of vision, and ultimately improve or restore visual capabilities for patients. The company is positioning itself as a significant player in the ophthalmic gene therapy sector, with the goal of enhancing patient autonomy while also contributing to reduced healthcare costs.

Ilmatar

Venture Round in 2021
Ilmatar is a project-oriented integrator in the field of renewable energy production with a strong focus on project execution. They make ideas come to life – ours as well as yours. Ilmatar aims at building 1 GW of new wind power capacity in Finland in the next five years. Through these, Ilmatar will have a remarkable positive effect in the reduction of carbon dioxide emissions in energy production. Ilmatar’s commitment to emission reduction offers a great legacy to future generations. Ilmatar identifies, develops, finances, constructs and operates renewable energy production sites. At the same time, they are constantly following the progress of new, carbon neutral or even carbon binding, energy systems to discover technologies and concepts that are mature enough for realization. Although Ilmatar is completely independent and free to pursue its own agenda for a cleaner future, they are not alone in their efforts, but enjoy the support of a vast network of domestic and international partners. Their most significant partners are Omnes Capital and EDF Renewables. Ilmatar’s local companies are in charge of the local project development, construction and operating of the wind farms. The group’s parent company is Ilmatar Windpower Plc.

Unseenlabs

Series B in 2021
Unseenlabs is a French company founded in 2015 and headquartered in Rennes, Brittany. It specializes in designing and developing spectrum surveillance payloads aimed at detecting and tracking non-cooperative vessels globally. The company provides comprehensive solutions that encompass all stages of satellite development, from design to launch. Through its technology, Unseenlabs contributes to maritime safety and security by monitoring maritime activities and enhancing situational awareness.

PeopleSpheres

Venture Round in 2021
PeopleSpheres offers HRIS software solution for human resources management. PeopleSpheres was formerly known as NeoSpheres SAS and changed its name to PeopleSpheres in September, 2019. The company was incorporated in 2010 and is based in Paris, France. As of September 5, 2019, PeopleSpheres operates as a subsidiary of Sopra HR Software SAS.

Elistair

Series B in 2021
Elistair SAS designs and manufactures industrial tethered drone systems. It provides SAFE-T, a tethered station for UAVs, offering real-time persistent observation capability and LIGH-T, a tethered station for drones offering aerial observation capabilities to drone operators, public safety, private security, traffic monitoring agencies, national security, and law enforcement units. The company was founded in 2014 and is based in Champagne-au-Mont-d'Or, France.

Artifakt

Series A in 2021
Artifakt SAS develops cloud platforms to deploy and manage web projects. The company offers Magento, a PHP open-source ecommerce solution for retailers and brands; and Akeneo, a product information management software for marketing teams. It also provides Wordpress, a PHP open-source software to create websites, blogs, and ecommerce sites; and Symfony, a PHP framework to build web applications, APIs, micro services, and web services. The company was founded in 2017 and is based in Paris, France.

AgomAb Therapeutics

Series B in 2021
AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.

Bizay

Series C in 2020
Bizay is an online printing solution that offers a customized marketplace platform for product personalization. The company specializes in digitalizing product customization, allowing brands and individuals to express themselves through tailored products. By providing a user-friendly interface, competitive pricing, and professional design options, Bizay caters to various customer segments, including small and medium-sized enterprises as well as larger brands. The platform facilitates the design and sale of customized products from an extensive catalog, leveraging technology to optimize supply chains and reduce production costs significantly. This approach transforms how businesses communicate and implement their marketing strategies, enhancing overall convenience and delivery speed.

AlgoTherapeutix

Series A in 2020
AlgoTherapeutix SAS is a biotechnology company founded in 2018 and located in Suresnes, France, focused on developing innovative topical treatments for complex pain conditions. The company's primary product, ATX01, is designed to alleviate peripheral neuropathic pain caused by chemotherapy. By targeting the damaged nerve fibers in the skin, AlgoTherapeutix aims to provide effective pain relief while minimizing the systemic side effects associated with oral medications. The company's approach also addresses other pain syndromes, such as erythromelalgia, thereby offering medical practitioners new options to enhance patient care for those suffering from chemotherapy-induced peripheral neuropathy.

Power Capital Renewable Energy

Acquisition in 2020
Power Capital Renewable Energy specialize in developing large scale photovoltaic solar farms. The company began by acquiring and asset managing utility scale solar parks.

Biosyl

Venture Round in 2020
Biosyl SAS operates as a holding company. The company, through its subsidiary, produce wood pallets for domestic stoves and pallet boilers. The company was founded in 2010 and is headquartered in Cosne-Cours-sur-Loire, France.

Sekoia.io

Series A in 2020
Sekoia SAS offers information technology and security consulting services. The company provides risk analysis, infrastructure management, security audits, technical and strategic audits, and security projects consulting services. Additionally, it offers business continuity planning, compliance, and information security management systems projects services. The company caters to banking, telecommunication, energy, government agencies, and service sectors. Sekoia SAS headquartered in Paris, France with additional office in Cesson-Sévigné, France.

AB Tasty

Series C in 2020
AB Tasty is a software company based in Paris, France, that specializes in providing experimentation, personalization, and product optimization solutions for marketing and product teams. Founded in 2009, the company enables businesses to enhance their digital assets and channels by turning website and mobile visitors into customers, subscribers, and leads. AB Tasty's platform supports various industries, including e-commerce, retail, travel, luxury, fashion, media, and financial services. It offers comprehensive features for feature management, experimentation, and personalization, helping organizations improve conversions, engagement, and revenue while ensuring customer experiences align with business objectives. The company collaborates with marketing and product teams, as well as agency and technology partners, to deliver effective customer success strategies.

Enterome

Series E in 2020
Enterome SA is a biotechnology company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, it specializes in disease management solutions that leverage its understanding of the gut microbiome. The company focuses on developing biomarkers, companion diagnostics, and therapeutics aimed at treating various microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. Enterome's innovative approach involves identifying bioactive molecules differentially expressed by the gut microbiome, which are crucial for regulating human physiology and immune responses. The company has established a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development efforts. By integrating its expertise in the gut microbiome with therapeutic development, Enterome aims to create targeted solutions for complex health challenges.

Dust Mobile

Venture Round in 2019
Dust Mobile is a mobile operator based in Brussels, Belgium, specializing in cyber security solutions for voice, text, and data communications. Founded in 2017, the company focuses on protecting against threats associated with cellular mobile network signaling, including 2G, 3G, 4G LTE, and 5G technologies. Dust Mobile offers secure proprietary SIM cards that are compatible with all smartphones and connected devices, along with comprehensive secure mobile communication plans. Its services include mobile network cyber security, transmission security, global coverage, and protection of information system access, ensuring users have a secure and reliable mobile experience.

TISSIUM

Series B in 2019
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery. TISSIUM is developing products that are non-toxic, bind strongly to tissues and deliver ‘on-demand’ wound closure within the ‘wet’ and dynamic environments in the body. The Company’s technology and products are based on world-class research and intellectual property from the laboratories of Robert Langer (MIT) and Jeff Karp (Brigham & Women’s Hospital). Gecko was founded in 2013 and is backed by leading healthcare investors Omnes Capital, CM-CIC and CapDecisif Manangement.

Solvionic

Venture Round in 2019
Solvionic SA is a technology start-up based in Varilhes, France, specializing in the development and manufacture of ionic liquid chemicals for various commercial and industrial applications. Founded in 2003, the company focuses on sustainable chemistry by employing innovative processes that aim to minimize energy consumption, reduce the use of raw materials, and decrease waste generation. Solvionic's products serve a range of industries, including pharmaceuticals, petrochemicals, energy storage, catalysis, surface treatment, extraction, and biotechnology. By providing improved and safe ionic chemicals, Solvionic aims to meet the demands of its clients in a cost-effective manner while contributing to environmental sustainability.

Biosyl

Venture Round in 2019
Biosyl SAS operates as a holding company. The company, through its subsidiary, produce wood pallets for domestic stoves and pallet boilers. The company was founded in 2010 and is headquartered in Cosne-Cours-sur-Loire, France.

Newronika

Series A in 2019
Newronika s.r.l. is a Milan-based company that specializes in the manufacture and marketing of neuromodulation systems aimed at addressing brain-related issues. Established in 2016 as a spin-off from prominent research institutions, including Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan, Newronika combines expertise from various fields such as neuroscience, neurophysiology, and biomedical engineering. The company offers innovative therapeutic tools like WebBioBank, a web-based platform utilizing transcranial direct current stimulation (tDCS) for long-term functional changes in the cerebral cortex, and the HDCkit system, which includes a programmable stimulator designed to enhance treatment efficacy while ensuring patient safety. Newronika's products are distributed in the United Kingdom and internationally, targeting chronic pain, cravings, depression, and stroke rehabilitation, ultimately aiming to improve patients' quality of life through precise stimulation techniques.

Wizaplace

Venture Round in 2019
Wizaplace is a software as a service platform based in Lyon, France, that specializes in the creation and management of online marketplaces. Established in 2012 and officially launched in 2015, the platform supports various marketplace models, including B2C, B2B, and C2C, as well as tailored service marketplaces. It features an integrated environment with approximately 70 modules that facilitate the development of diverse e-commerce solutions, e-services, crowdfunding initiatives, and collaborative platforms. The company was co-founded and is run by Eric and Cécile Alessandri, and as of January 2017, it had a team of around 20 employees.

Themis Bioscience

Series D in 2019
Themis Bioscience is a start-up biotechnology company developing vaccines to prevent infectious diseases. The company’s development focus is primarily concentrated on emerging and specialist indications, advancing promising vaccines from preclinical to late-stage clinical development phases. We aim to exploit the increasing licensing and acquisition trend to generate value by developing and partnering our technology programs and vaccine candidates. It is our mission to establish Themis as a first class biotech development boutique and to become a preferred licensing partner for leading biotech and pharmaceutical companies.

Spherea

Venture Round in 2019
A company that provides solutions for critical electronic and optronic system testing globally.

Bankin

Series B in 2019
Bankin' is the Best Mobile Money Manager. Bankin' app makes money management super easy. At Bankin', they believe that money management must be simple, transparent and efficient so you can focus on what really matters to you. Their mission is to bring innovation and technology together to offer you the best solution to guide you every day. They are the leader in Europe: you are more than 1.5 million to trust us in France, in England, in Spain, and in Germany. They are the only company independent of banks in Europe. It is something they feel very strongly about because it allows us to provide better guidance by always suggesting what's right for you.

NH TherAguix

Series A in 2019
NH TherAguix SAS, a clinical stage pharmaceutical company, develops nanomedicines for cancer, combining imaging, and radiotherapy. It offers AGuIX, a nanoparticle that is designed to improve the localization of solid tumors and the outcomes of radiation therapy by intravenous injection; allows the radiation therapy treatment for patient to determine the optimal moment to perform the irradiation; and allows to treat radioresistant cancers and to minimize the radiation therapy secondary effects by decreasing the dose to healthy tissues. The company was founded in 2015 and is based in Villeurbanne, France.

AgomAb Therapeutics

Series A in 2019
AgomAb is developing molecular therapies for the regeneration of damaged tissues. Their unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.

Therapixel

Series A in 2019
Therapixel SA designs and develops medical image analytics software for surgeons. The company's products are based on artificial intelligence. Its products include Radvise, an automatic image reading solution; Fluid, a touchless medical image navigation for surgery; Anywhere, a post-processing workstation; and CD-Feed, a CD imports solution for outpatient imaging exams. Therapixel SA was founded in 2013 and is headquartered in Valbonne, France and has additional locations in Australia, China, Pakistan, Iran, Turkey, Poland, Italy, Spain, France, Mexico, Brazil, Chile, and Peru.

Teach on Mars

Venture Round in 2019
Teach On Mars SAS develops a learning platform for web and mobile devices. The company offers a mobile learning portal for smartphones and tablets. Its solution allows trainers to create mobile courses and learning games; manage learners and training courses; and consult learning analytics, including progression charts, attendance reports, scores, and learner rankings. The company also offers packaged content apps, including Learn on Mars, an app to create a personalized mobile learning app; and Quiz on Mars, a social and engaging learning game. In addition, it offers mobile learning training and certification, support, app marketing, integration, learning design, and professional content marketplace services. The company was founded in 2013 and is based in Sophia Antipolis, France with an additional office in Paris, France.

Bizay

Series B in 2018
Bizay is an online printing solution that offers a customized marketplace platform for product personalization. The company specializes in digitalizing product customization, allowing brands and individuals to express themselves through tailored products. By providing a user-friendly interface, competitive pricing, and professional design options, Bizay caters to various customer segments, including small and medium-sized enterprises as well as larger brands. The platform facilitates the design and sale of customized products from an extensive catalog, leveraging technology to optimize supply chains and reduce production costs significantly. This approach transforms how businesses communicate and implement their marketing strategies, enhancing overall convenience and delivery speed.

ABMI

Venture Round in 2018
ABMI Corporate SAS is a multi-specialist company based in Guyancourt, France, focused on various engineering and industrial services. Established in 1984, the company offers product engineering solutions across multiple sectors, including automotive, aerospace, defense, and heavy industries. Their expertise extends to software and electronic engineering, encompassing software development, card design, and project management. Additionally, ABMI provides process engineering services such as auditing and the establishment of manufacturing lines. The company also specializes in industrial installation, offering comprehensive services that include site design, project management, and commissioning across sectors like energy, chemicals, pharmaceuticals, and food. With branch offices throughout France and Europe, ABMI operates in a rapidly growing market, delivering tailored solutions to meet diverse client needs.

Captain Tortue

Funding Round in 2018
Captain Tortue is the European leader in direct selling women's ready-to-wear clothing. Every year, it designs around 330 models through its four brands: Trend (trendy collection, urban chic), Miss (classic and casual collection), Little Miss (children's collections, teenagers and small sizes) and Java (home wear comfort-casual).

Sentryo

Series A in 2018
Sentryo SAS develops and provides cybersecurity and situational awareness solutions. Its solutions enable corporations to ensure continuity, resilience and safety of industrial operations by providing continuous visibility over Industrial Control Systems (ICS) and SCADA infrastructures and controlling the risks of cyber attacks. The company’s product ICS CyberVision allows control engineers to gain complete visibility over all equipment connected to their industrial networks and identifies vulnerabilities on those networks and is able to take decisions that can ensure the integrity of the system. The company was founded in 2014 and is based in Villeurbanne, France. As of August 8, 2019, Sentryo SAS operates as a subsidiary of Cisco Systems, Inc.

Intersec

Venture Round in 2018
Intersec SA is a software company based in Paris, France, with an additional office in London, specializing in streaming analytics solutions for various sectors, including telecommunications, utilities, manufacturing, financial services, and retail. Founded in 2004, the company focuses on transforming large volumes of data from diverse network equipment and IT systems into actionable insights in real-time. Intersec's offerings include customer base management, location data monetization, fraud management, public safety, IoT analytics, and messaging solutions. Its innovative platforms support applications such as contextual marketing, geolocation intelligence, smart cities, and business analytics. Recognized for its contributions to the industry, Intersec received awards for its innovative location-based services and cloud analytics solutions in 2017, and it operates solutions globally.

GEEV

Venture Round in 2018
GEEV SAS develops an application that enables the user to donate their stuff and find new free stuff posted by other users in their area. The application helps to find stuff nearby, direct messaging, turn giving into a game, and mange user profile. The application features include search and map view, friends sponsorship, and editable profile. The company was founded in 2017 and is based in Bordeaux, France.

Antabio

Series A in 2018
Antabio SAS develops drugs that block the virulence of bacteria. It offers molecules for the treatment of antibiotics resistant nosocomial infections. The company develops and MBLi: Metallo Beta-Lactamase inhibitor, an inhibitor of bacterial MBLs; discovered SBLi: Serine Beta-Lactamase inhibitor, SBL inhibitor with broad coverage against key SBL enzymes, including ESBLs, KPC and OXA-type carbapenemases in Enterobacteriaceae and Acinetobacter baumannii; and PEi : Pseudomonas Elastase inhibitors (powered by CARB-X), an inhaled drug which can be used as an adjunct to existing antibiotic therapy and which will reduce the frequency and severity of Pseudomonas exacerbations by targeting the three corner-stones of Pseudomonas pathogenesis: virulence, stealthiness and persistence. Antabio SAS was founded in 2009 and is based in Labège, France.

Marquetis

Debt Financing in 2018
Marquetis & Co, founded in 1996 and headquartered in Boulogne Billancourt, France, specializes in operational marketing services within the French marketing and communications sector. The company has been managed for over two decades by Virginie Massa and Evangelos Vatzias. Marquetis operates through its subsidiaries, which include Marquetis One, Marquetis Connect, and Marquetis Call. It provides a comprehensive range of services that encompass global communication consulting and automated cross-channel marketing solutions delivered in a Software as a Service (SaaS) model.

Tiller Systems

Series B in 2018
Tiller Systems SAS develops iPad point of sale (POS) software solution for restaurants and merchants. The company’s POS management tool allows restaurant managers and merchants to make smarter decisions. Tiller Systems SAS was founded in 2014 and is based in Paris, France with additional offices in Barcelona, Italy; and Milan, Italy.

Mistral Informatique

Acquisition in 2018
The Mistral group markets an integrated software solution (ERP) dedicated to the market and the business of dealers, renters, resellers of agricultural equipment and construction equipment. The group consists of two entities, Mistral Informatique (publisher of software and mobility applications) and Mistral DataCenter (hosting and outsourcing services).

Nanomakers

Venture Round in 2018
Nanomakers is a start-up that designs, manufactures and markets industrial quantities of silicon-based, patented nano-scale powders for disruptive mechanical reinforcement of materials (metal alloys, elastomers) and doubling the energy storage density of lithium-ion batteries. ion with nano-composites Si-C for the anode. Nanopowders of silicon carbide (SiC) and silicon (Si) significantly increase the performance of industrial materials.

Tilkee

Series A in 2018
Tilkee SARL operates an online platform designed to enhance the submission and tracking of business proposals across various sectors. Founded in 2012 and based in Lyon, France, the platform allows professionals to create and host customized commercial proposals easily. Users can upload sales documents, generate branded online proposals, and share unique access links with potential clients. Tilkee's technology provides real-time notifications about prospect engagement, detailing which documents were read, the duration of engagement, and specific areas of interest. This functionality helps sales teams optimize their follow-up strategies and improve their closing rates.

ForCity

Series A in 2018
ForCity, based in Lyon, France, is a developer of decision support services and 4D urban simulation software aimed at policy-makers and business decision-makers. Founded in 2014, the company offers a collaborative platform that allows users to simulate projects in a digital environment, where geographical features and infrastructure are modeled to assess their interactions. Utilizing complex systems modeling and a user-friendly 2D-3D visualization engine, ForCity's applications enable real-time simulations that help users anticipate the impacts of their investments and facilitate collaboration among project stakeholders. The company's services are utilized by clients worldwide, enhancing planning and decision-making processes in urban development.

VSORA

Series A in 2018
VSORA SAS provides digital signal processing (DSP) intellectual property (IP) for 5G wireless networks. Its products include single-core processor and multi-core processor. The company was founded in 2015 and is based in Velizy-Villacoublay, France.

Pherecydes Pharma

Series B in 2018
Pherecydes Pharma SA engages in the research and development of lytic bacteriophages for therapeutic and diagnostic applications with a focus on antibiotic resistance. It develops several banks of bacteriophages, including the collection of phages against Escherichia coli. The company was incorporated in 2006 and is based in Romainville, France.

Enterome

Debt Financing in 2018
Enterome SA is a biotechnology company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, it specializes in disease management solutions that leverage its understanding of the gut microbiome. The company focuses on developing biomarkers, companion diagnostics, and therapeutics aimed at treating various microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. Enterome's innovative approach involves identifying bioactive molecules differentially expressed by the gut microbiome, which are crucial for regulating human physiology and immune responses. The company has established a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development efforts. By integrating its expertise in the gut microbiome with therapeutic development, Enterome aims to create targeted solutions for complex health challenges.

Themis Bioscience

Series C in 2018
Themis Bioscience is a start-up biotechnology company developing vaccines to prevent infectious diseases. The company’s development focus is primarily concentrated on emerging and specialist indications, advancing promising vaccines from preclinical to late-stage clinical development phases. We aim to exploit the increasing licensing and acquisition trend to generate value by developing and partnering our technology programs and vaccine candidates. It is our mission to establish Themis as a first class biotech development boutique and to become a preferred licensing partner for leading biotech and pharmaceutical companies.

Horama SAS

Series B in 2017
Horama SAS is a biotechnology company based in Paris, France, established in 2014. It specializes in developing gene therapy products aimed at treating rare ophthalmic diseases, particularly targeting inherited retinal dystrophies and retinopathies. By utilizing recombinant adeno-associated viral vectors, Horama's therapies aim to deliver a functional copy of mutated genes to affected retinal cells. This approach seeks to restore normal cell function, prevent further deterioration of vision, and ultimately improve or restore visual capabilities for patients. The company is positioning itself as a significant player in the ophthalmic gene therapy sector, with the goal of enhancing patient autonomy while also contributing to reduced healthcare costs.

Aero Negoce International

Venture Round in 2017
Aero Negoce International, SAS manufactures industry fasteners and hardware for aerospace industry. Its products include fasteners, spherical plain bearings, connectors, lamps, seals, and hinges. The company also provides contract management and consignment stock and custom packing services. The company was founded in 1993 and is headquartered in Beziers, France.

Groupe InCa

Acquisition in 2017
Groupe InCa is one of the regional leaders in the construction of built-to-order single-design detached homes, with three strong brands in Nouvelle Aquitaine: Maisons Clairlande, Les Demeures de la Côte d’Argent and Rouquié Constructions. The Group has a wide range of target customers, from first-time buyers to high-end customers.

AB Tasty

Series B in 2017
AB Tasty is a software company based in Paris, France, that specializes in providing experimentation, personalization, and product optimization solutions for marketing and product teams. Founded in 2009, the company enables businesses to enhance their digital assets and channels by turning website and mobile visitors into customers, subscribers, and leads. AB Tasty's platform supports various industries, including e-commerce, retail, travel, luxury, fashion, media, and financial services. It offers comprehensive features for feature management, experimentation, and personalization, helping organizations improve conversions, engagement, and revenue while ensuring customer experiences align with business objectives. The company collaborates with marketing and product teams, as well as agency and technology partners, to deliver effective customer success strategies.

Batiweb.com

Venture Round in 2017
Batiweb.com is a BtoB web portal focusing on the housing and construction sectors. The company has grown based on a directory/ search engine business model focusing on construction products and is now one of the established leaders on its market. By continuing to broaden its product offering, Batiweb aims to become the no. 1 internet group dedicated to construction, housing and decoration.

RGF GROUP

Acquisition in 2017
RGF Group, plastic injection specialist, combines the know-how and technical skills ti support you in your industrial challenge. Equipped with the lastest technology in mono and bi-injection machine, RGF Group will gather also in the conception of your equipment (injection tools, turning parts, marking, assembly...) Always close to you and human-size, RGF Group is extremely happy to apply all their experience at your service, dynamism, reactivity and flexibility in all our production plants in France and worlwide.

MultiX

Venture Round in 2017
MultiX supplies system manufacturers with advanced multi energy technology allowing OEMs to significantly reduce the false alarm rate of baggage screening systems for airports and sensitive infrastructure. The new X-Ray detectors are also applicable to non-destructive testing (NDT) applications such as food processing, mining, recycling, waste product processing, petroleum production, forest products, packaging and many others. MultiX technology allows airport operators to improve passenger facilitation and experience at checkpoints by reducing the need to divest liquids and laptops from their hand baggage while meeting the ever more stringent security regulations.

Circet

Venture Round in 2017
Circet is a recognized leader in the construction and maintenance of fixed and mobile telecommunications networks. The company specializes in providing turnkey solutions and process industrialization, demonstrating agility and flexibility in its operations. Serving telecom operators and large user accounts, Circet has established itself as a pioneer in the industry, focusing on efficient and effective service delivery to meet the evolving needs of its clients.

OCTIMET Oncology

Series A in 2017
OCTIMET oncology’s overall strategy is to advance the development of discovery stage molecules by employing innovative patient selection and pharmacodynamic biomarker-based strategies, as well as an innovative clinical development strategy.

Bankin

Series A in 2017
Bankin' is the Best Mobile Money Manager. Bankin' app makes money management super easy. At Bankin', they believe that money management must be simple, transparent and efficient so you can focus on what really matters to you. Their mission is to bring innovation and technology together to offer you the best solution to guide you every day. They are the leader in Europe: you are more than 1.5 million to trust us in France, in England, in Spain, and in Germany. They are the only company independent of banks in Europe. It is something they feel very strongly about because it allows us to provide better guidance by always suggesting what's right for you.

Enterome

Series D in 2017
Enterome SA is a biotechnology company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, it specializes in disease management solutions that leverage its understanding of the gut microbiome. The company focuses on developing biomarkers, companion diagnostics, and therapeutics aimed at treating various microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. Enterome's innovative approach involves identifying bioactive molecules differentially expressed by the gut microbiome, which are crucial for regulating human physiology and immune responses. The company has established a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development efforts. By integrating its expertise in the gut microbiome with therapeutic development, Enterome aims to create targeted solutions for complex health challenges.

Ducatillon

Acquisition in 2016
Ducatillon specializes in the catalog and internet distribution of breeding equipment for amateurs or families with pets, poultry, goat rabbits and sheep. It also develops for its passionate hunting clientele the sale of equipment, equipment and accessories for the hunter and his hunting dogs.

Themis Bioscience

Series B in 2016
Themis Bioscience is a start-up biotechnology company developing vaccines to prevent infectious diseases. The company’s development focus is primarily concentrated on emerging and specialist indications, advancing promising vaccines from preclinical to late-stage clinical development phases. We aim to exploit the increasing licensing and acquisition trend to generate value by developing and partnering our technology programs and vaccine candidates. It is our mission to establish Themis as a first class biotech development boutique and to become a preferred licensing partner for leading biotech and pharmaceutical companies.

Oxatis

Series D in 2016
Oxatis SA is a company based in Marseille, France, that specializes in providing e-commerce technology solutions across Europe. Founded in 2001, Oxatis offers a range of tools designed to assist small businesses in creating comprehensive websites. Their services include an online content management system, hosting, and an integrated shopping cart, enabling users to establish an online presence and conduct sales without requiring prior technical expertise or significant financial investment. Through its software-as-a-service model, Oxatis aims to empower merchants by simplifying the process of setting up and managing online stores.

Bizay

Series A in 2016
Bizay is an online printing solution that offers a customized marketplace platform for product personalization. The company specializes in digitalizing product customization, allowing brands and individuals to express themselves through tailored products. By providing a user-friendly interface, competitive pricing, and professional design options, Bizay caters to various customer segments, including small and medium-sized enterprises as well as larger brands. The platform facilitates the design and sale of customized products from an extensive catalog, leveraging technology to optimize supply chains and reduce production costs significantly. This approach transforms how businesses communicate and implement their marketing strategies, enhancing overall convenience and delivery speed.

European Games Group

Venture Round in 2016
European Games Group AG engages in commercialization of free2play cross-platform online/mobile games. It offers a single game, shared risk, shared profit, and pre-financed joint venture, which enables developers to launch and market their Free2Play browser-based games worldwide. European Games Group AG was founded in 2010 and is based in Munich, Germany.

Adents

Series B in 2016
Adents is a provider of premier serialization solutions for unique product identification and traceability.

Enterome

Series C in 2016
Enterome SA is a biotechnology company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, it specializes in disease management solutions that leverage its understanding of the gut microbiome. The company focuses on developing biomarkers, companion diagnostics, and therapeutics aimed at treating various microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. Enterome's innovative approach involves identifying bioactive molecules differentially expressed by the gut microbiome, which are crucial for regulating human physiology and immune responses. The company has established a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development efforts. By integrating its expertise in the gut microbiome with therapeutic development, Enterome aims to create targeted solutions for complex health challenges.

Babbler

Series A in 2016
Babbler, founded in 2013 by sisters Hannah and Sarah, is a pioneering platform designed specifically for media relations. Hannah, with a background in digital strategy from companies like Coca-Cola and Microsoft, and Sarah, an experienced public relations professional, created Babbler to facilitate real-time communication between brands and media professionals. The platform enables users to share news, files, and messages instantly, enhancing engagement and interaction within media communities. Babbler has garnered recognition for its innovative approach, winning the French Microsoft Imagine Cup in 2013 and being featured in Challenges Magazine’s list of the Top 100 Best Start-ups to Invest In. It has also attracted significant investment from notable entities in the PR and advertising sectors.

TISSIUM

Series A in 2016
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery. TISSIUM is developing products that are non-toxic, bind strongly to tissues and deliver ‘on-demand’ wound closure within the ‘wet’ and dynamic environments in the body. The Company’s technology and products are based on world-class research and intellectual property from the laboratories of Robert Langer (MIT) and Jeff Karp (Brigham & Women’s Hospital). Gecko was founded in 2013 and is backed by leading healthcare investors Omnes Capital, CM-CIC and CapDecisif Manangement.

Intersec

Series C in 2016
Intersec SA is a software company based in Paris, France, with an additional office in London, specializing in streaming analytics solutions for various sectors, including telecommunications, utilities, manufacturing, financial services, and retail. Founded in 2004, the company focuses on transforming large volumes of data from diverse network equipment and IT systems into actionable insights in real-time. Intersec's offerings include customer base management, location data monetization, fraud management, public safety, IoT analytics, and messaging solutions. Its innovative platforms support applications such as contextual marketing, geolocation intelligence, smart cities, and business analytics. Recognized for its contributions to the industry, Intersec received awards for its innovative location-based services and cloud analytics solutions in 2017, and it operates solutions globally.

AB Tasty

Series A in 2016
AB Tasty is a software company based in Paris, France, that specializes in providing experimentation, personalization, and product optimization solutions for marketing and product teams. Founded in 2009, the company enables businesses to enhance their digital assets and channels by turning website and mobile visitors into customers, subscribers, and leads. AB Tasty's platform supports various industries, including e-commerce, retail, travel, luxury, fashion, media, and financial services. It offers comprehensive features for feature management, experimentation, and personalization, helping organizations improve conversions, engagement, and revenue while ensuring customer experiences align with business objectives. The company collaborates with marketing and product teams, as well as agency and technology partners, to deliver effective customer success strategies.

MesDocteurs

Seed Round in 2016
MesDocteurs provides health advice and information. The company intends to use the funds to strengthen its teams, launch a B2B service aimed at insurance companies and mutual organisations, set up a video/audio chat line, make the app available on Android and obtain the various approvals needed to offer users an online consultation service in the next few months.

Dispam

Venture Round in 2015
Dispam offers comprehensive range of high value-added solutions structured around two main areas of expertise including temperature-controlled (positive cold) transportation of fresh produce and general cargo and complementary logistics services for its clients.

Capcom groupe

Venture Round in 2015
Capcom Groupe SARL provides deployment, installation, and technical maintenance services of fiber optic telecommunications networks to telecoms operators. The company was founded in 2001 and is based in Marly, France. As of February 23, 2017, Capcom Groupe SARL operates as a subsidiary of Groupe Circet S.A.

SeniorAdom

Venture Round in 2015
Founded in November 2012, SeniorAdom offers new remote assistance technology. SeniorAdom’s next-generation technology automatically detects falls and sudden illness using a smart system of detectors (no cameras) connected to a central device. This central device is easy to install and use. It can simply be plugged into a power socket (no need for an internet connection because it has an embedded GSM mobile phone card). No special training is required. In addition to falls and sudden illness, SeniorAdom’s solution can also report any unusual patterns in the life of a dependent person by sending a text or email to their carer. Each carer has a personalised and secure space from which they can monitor the well-being of the person living in their own home. SeniorAdom has genuinely disrupted the remote assistance space, which had barely advanced in 35 years. It provides comfort and peace of mind to both carers and service users.

TVSmiles

Series B in 2015
TVSmiles is a quiz app that rewards users with so-called smiles for interacting with various TV and digital advertising formats. Their mission is to get the most out of advertisements and turn viewers into customers again. The app combines ads, games, and an extensive mobile loyalty program in a unique way. Instead of simply showing ungainly ads that aren’t adapted to mobile. TVSmiles was launched in 2013 and is based in Berlin, Germany.

Bimedia

Venture Round in 2015
Bimedia offers unique know-how in management and collection solutions for tobacconists, newsagents, bakeries, cafés and restaurants ... Their software and hardware solutions make it easier to manage and manage more than 6,000 outlets. Helping you sell more and better in the shop is a priority for us: for 15 years, we have favored innovation to put it at the service of local shops (mobile checkout systems, touch screens, dual screens, numerous dematerialized services, etc.). )

Scality

Series D in 2015
Scality, Inc. specializes in software-defined storage solutions designed for active archives, content distribution, cloud services, and enterprise environments. Founded in 2009 and headquartered in San Francisco, with an additional office in Cambridge, Massachusetts, Scality's flagship product, RING, enables users to scale storage to petabytes while ensuring high performance and data protection. The RING architecture supports billions of files and delivers 100% availability, making it suitable for large-scale applications. It integrates seamlessly with various standard storage protocols, including NFS and S3. Scality's customer base includes major players in the media and telecommunications sectors, including some of the largest cable operators and mobile operators in the US, Europe, and Japan. Additionally, Scality offers the HALO Cloud Monitor, a comprehensive monitoring solution for its storage platform, enhancing operational efficiency and reliability.

Adents

Series A in 2015
Adents is a provider of premier serialization solutions for unique product identification and traceability.

The Luneau Technology Group

Private Equity Round in 2015
Luneau Technology Operations SAS develops, manufactures, and markets refraction and diagnostic instruments for optometrists, ophthalmologists, and practitioners. The company provides edging systems and industrial solutions for opticians, laboratories, and central workshops. It offers its products for refraction and ophthalmic diagnosis, lens inspection, and lens finishing needs. The company was founded in 1926 and is based in Pont-de-l'Arche, France. Luneau Technology Operations SAS operates as a subsidiary of Visionix Ltd.

Cogepart

Venture Round in 2015
COGEPART GROUPE provides shipping and delivery services for retail and business customers. The company operates a fleet of 350 motor vehicles. COGEPART GROUPE was founded in 1986 and is based in Marseille, France.

Heidrich

Acquisition in 2014
Heidrich is specialises in buying, selling and fitting external joinery (windows, doors, shutters, garage doors, etc.).

APF Pool Design

Acquisition in 2014
APF Pool Design, based in Annonay, France, specializes in the production of swimming pool equipment, including liners, summer and winter covers, and automatic shutters. As a leader in its field, the company manufactures a variety of products such as isothermal and safety covers, liner rollers, and filtration accessories. Additionally, APF Pool Design offers distribution of roller mechanisms and various materials, including PVC-coated fabrics. The company also provides innovative solutions for remote swimming pool control, allowing clients to program pumps and filtration systems easily. Established in 1995, APF Pool Design combines expertise in design and manufacturing to deliver quality products for swimming pool maintenance and safety.

Enterome

Series B in 2014
Enterome SA is a biotechnology company based in Paris, France, with an additional office in Cambridge, Massachusetts. Founded in 2008, it specializes in disease management solutions that leverage its understanding of the gut microbiome. The company focuses on developing biomarkers, companion diagnostics, and therapeutics aimed at treating various microbiome-related diseases, including inflammatory bowel diseases and metabolic disorders. Enterome's innovative approach involves identifying bioactive molecules differentially expressed by the gut microbiome, which are crucial for regulating human physiology and immune responses. The company has established a strategic collaboration with Takeda Pharmaceutical Company to enhance its research and development efforts. By integrating its expertise in the gut microbiome with therapeutic development, Enterome aims to create targeted solutions for complex health challenges.

ACCO Semiconductor

Series E in 2014
ACCO Semiconductor, Inc., a fabless semiconductor company, develops CMOS wireless solutions. It offers various CMOS power amplifier products that support 2G/3G/4G cellular standards for portable mobile products, including mobile phones (smartphones and feature-phones), wireless tablets, MiFi routers, USB dongles, and other devices. The company was founded in 1994 and is based in Sunnyvale, California. It has facilities in Paris, France; and Sunnyvale, California.

Oxatis

Series C in 2014
Oxatis SA is a company based in Marseille, France, that specializes in providing e-commerce technology solutions across Europe. Founded in 2001, Oxatis offers a range of tools designed to assist small businesses in creating comprehensive websites. Their services include an online content management system, hosting, and an integrated shopping cart, enabling users to establish an online presence and conduct sales without requiring prior technical expertise or significant financial investment. Through its software-as-a-service model, Oxatis aims to empower merchants by simplifying the process of setting up and managing online stores.

Cooltech Applications

Venture Round in 2013
COOLTECH APPLICATIONS SAS develops and commercializes magnetic refrigeration products for commercial refrigeration equipment manufacturing markets. It also offers custom development solutions, such as magnetocaloric materials and magnetocaloric systems. The company serves refrigeration markets, such as commercial refrigeration, transport, industrial cold, and home appliance markets; and air conditioning markets, including automotive, residential, and commercial markets worldwide. COOLTECH APPLICATIONS SAS was founded in 2003 and is headquartered in Holtzheim, France with additional offices in Paris.

TISSIUM

Series A in 2013
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery. TISSIUM is developing products that are non-toxic, bind strongly to tissues and deliver ‘on-demand’ wound closure within the ‘wet’ and dynamic environments in the body. The Company’s technology and products are based on world-class research and intellectual property from the laboratories of Robert Langer (MIT) and Jeff Karp (Brigham & Women’s Hospital). Gecko was founded in 2013 and is backed by leading healthcare investors Omnes Capital, CM-CIC and CapDecisif Manangement.

Pixium Vision

Series A in 2013
Pixium Vision is a bioelectronics company based in Paris, France, focused on developing retinal implant systems to restore sight for individuals blinded by retinal degenerative diseases. The company is known for its PRIMA System, a bionic vision solution designed to treat blindness caused by the degeneration of photoreceptor cells in the retina. Pixium's initial device, the IRIS1, utilizes an epi-retinal implant and is undergoing clinical trials aimed at obtaining regulatory approval. A second-generation device, IRIS2, is in development, promising enhanced visual acuity through advanced technologies. Additionally, the company is working on IRIS3, a sub-retinal implant that aims to significantly improve vision compared to its predecessors. Established in 2011 as a spin-out from the Vision Institute and Université Pierre et Marie Curie, Pixium collaborates with several prestigious institutions, including Stanford University and Moorfields Eye Hospital, and is supported by prominent European venture capital firms.

Camerus

Acquisition in 2013
Camerus SAS specializes in the rental and leasing of furniture targeted at decorators, trade fairs, congress organizers, and event agencies. Founded in 1992 and headquartered in Gonesse, France, the company provides a wide range of furniture options including chairs, armchairs, lounges, tables, desks, display units, and multimedia systems. Its offerings cater to various large-scale events, such as trade shows and congresses, with additional products like floral-décor systems and accessories. Camerus also has locations in major French cities, including Paris, Lyon, and Toulouse.

Opsona

Series C in 2013
Opsona Therapeutics is a drug development firm based in Dublin, Ireland, specializing in innovative approaches to immunology. Founded in 2004, the company focuses on developing novel therapeutic strategies that target the innate immune system, which plays a crucial role in various major human diseases. These include autoimmune and inflammatory diseases, cancer, transplant rejection, diabetes, Alzheimer's disease, and atherosclerosis. By modulating the human innate immune response, Opsona aims to create new drug candidates that can significantly improve treatment outcomes for patients facing these challenging health issues.

ProDealCenter

Venture Round in 2013
Developer of an e-commerce platform designed to help in the purchase of agricultural products on the Internet.

Eratome SAS

Private Equity Round in 2013
Eratome group is a leading player in the building repair and maintenance and the social housing renovation and refurbishment markets.